PhenomeX (CELL) Stock

Profile

Full Name:

PhenomeX Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Indexes:

Not included

Description:

PhenomeX Inc. operates as a functional cell biology company. The company enables scientists to reveal insights on cell function and obtain behavior of each cell. Its suite of tools and services offer unparalleled resolution and speed, accelerating the insights for advancing discoveries that can profoundly improve the prevention and treatment of disease. The company's platforms are used by researchers worldwide, including pharmaceutical companies and comprehensive cancer centers. PhenomeX Inc. is headquartered in Emeryville, California. As of September 29, 2023, PhenomeX Inc. operates as a subsidiary of Bruker Corporation.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 08, 2023

Recent annual earnings:

Feb 23, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

23 Aug '23 TD Cowen
Market Perform
22 Aug '23 Berenberg
Hold
18 Aug '23 Morgan Stanley
Equal-Weight
12 May '23 Stifel
Hold
10 Aug '22 Morgan Stanley
Underweight
10 Aug '22 JP Morgan
Neutral
10 Aug '22 BTIG
Neutral
10 May '22 Morgan Stanley
Equal-Weight
25 Feb '22 Morgan Stanley
Equal-Weight
15 Feb '22 Morgan Stanley
Equal-Weight

Screeners with CELL included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

Grid Battery-Engages i2i Marketing Group, LLC for Marketing Program
Grid Battery-Engages i2i Marketing Group, LLC for Marketing Program
Grid Battery-Engages i2i Marketing Group, LLC for Marketing Program
CELL
accesswire.com16 August 2024

COQUITLAM, BC / ACCESSWIRE / August 16, 2024 / Grid Battery Metals Inc. (the "Company" or "Grid") (TSXV:CELL)(OTCQB:EVKRF)(FRA:NMK2) is pleased to announce that it has engaged i2i Marketing Group, LLC ("i2i") of Key West Florida, and has entered into a Marketing Agreement dated August 15, 2024, whereby i2i will provide a marketing and media distribution for an initial term of four months commencing upon TSX Venture Exchange ("Exchange") approval for a fee of US$600,000. Upon Exchange approval, the Company will pay i2i an initial deposit of US$150,000 to write and design the creative for an advertising campaign.

Grid Battery Metals Completes Phase 2 of its 2024 Clayton Valley Project 2024 Exploration Plan
Grid Battery Metals Completes Phase 2 of its 2024 Clayton Valley Project 2024 Exploration Plan
Grid Battery Metals Completes Phase 2 of its 2024 Clayton Valley Project 2024 Exploration Plan
CELL
accesswire.com20 June 2024

COQUITLAM, BC / ACCESSWIRE / June 20, 2024 / Grid Battery Metals Inc. (the "Company" or "Grid") (TSXV:CELL)(OTCQB:EVKRF)(FRA:NMK2) is pleased to announce the conclusion of a second phase of soil samples and the construction of a geologic model incorporating mapped geology, magnetotelluric (MT) geophysics, and soil geochemistry. Grid's exploration team has determined that a multilayered approach to drill targets would improve the chances of intercepting lithium bearing brines.

PhenomeX Inc. (CELL) Reports Q1 Loss, Lags Revenue Estimates
PhenomeX Inc. (CELL) Reports Q1 Loss, Lags Revenue Estimates
PhenomeX Inc. (CELL) Reports Q1 Loss, Lags Revenue Estimates
CELL
Zacks Investment Research11 May 2023

PhenomeX Inc. (CELL) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.32 per share a year ago.

PhenomeX to Report First Quarter 2023 Financial Results on May 11, 2023
PhenomeX to Report First Quarter 2023 Financial Results on May 11, 2023
PhenomeX to Report First Quarter 2023 Financial Results on May 11, 2023
CELL
PRNewsWire27 April 2023

EMERYVILLE, Calif. , April 27, 2023 /PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Company will be reporting financial results for the first quarter 2023 after market on Thursday, May 11, 2023.

FAQ

  • What is the primary business of PhenomeX?
  • What is the ticker symbol for PhenomeX?
  • Does PhenomeX pay dividends?
  • What sector is PhenomeX in?
  • What industry is PhenomeX in?
  • What country is PhenomeX based in?
  • Is PhenomeX in the S&P 500?
  • Is PhenomeX in the NASDAQ 100?
  • Is PhenomeX in the Dow Jones?
  • When was PhenomeX's last earnings report?
  • When does PhenomeX report earnings?
  • Should I buy PhenomeX stock now?

What is the primary business of PhenomeX?

PhenomeX Inc. operates as a functional cell biology company. The company enables scientists to reveal insights on cell function and obtain behavior of each cell. Its suite of tools and services offer unparalleled resolution and speed, accelerating the insights for advancing discoveries that can profoundly improve the prevention and treatment of disease. The company's platforms are used by researchers worldwide, including pharmaceutical companies and comprehensive cancer centers. PhenomeX Inc. is headquartered in Emeryville, California. As of September 29, 2023, PhenomeX Inc. operates as a subsidiary of Bruker Corporation.

What is the ticker symbol for PhenomeX?

The ticker symbol for PhenomeX is NASDAQ:CELL

Does PhenomeX pay dividends?

No, PhenomeX does not pay dividends

What sector is PhenomeX in?

PhenomeX is in the Healthcare sector

What industry is PhenomeX in?

PhenomeX is in the Biotechnology industry

What country is PhenomeX based in?

PhenomeX is headquartered in United States

Is PhenomeX in the S&P 500?

No, PhenomeX is not included in the S&P 500 index

Is PhenomeX in the NASDAQ 100?

No, PhenomeX is not included in the NASDAQ 100 index

Is PhenomeX in the Dow Jones?

No, PhenomeX is not included in the Dow Jones index

When was PhenomeX's last earnings report?

PhenomeX's most recent earnings report was on 8 November 2023

When does PhenomeX report earnings?

The date for PhenomeX's next earnings report has not been announced yet

Should I buy PhenomeX stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions